Quantcast
Home > Quotes > MCRB

Seres Therapeutics, Inc. Common Stock (MCRB) Quote & Summary Data

MCRB 
$8.21
*  
0.07
0.85%
Get MCRB Alerts
*Delayed - data as of Nov. 15, 2018  -  Find a broker to begin trading MCRB now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    MCRB After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 7.55 / $ 9.30
1 Year Target
15.5
Today's High / Low
$ 8.55 / $ 8.0963
Share Volume
135,608
50 Day Avg. Daily Volume
122,607
Previous Close
$ 8.28
52 Week High / Low
$ 11.345 / $ 5.64
Market Cap
335,427,013
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.62
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.8

Intraday Chart

Shares Traded

Share Volume:
135,608
50 Day Avg. Daily Volume:
122,607

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.62

Trading Range

The current last sale of $8.21 is 45.57% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 8.55 $ 11.345
 Low: $ 8.0963 $ 5.64

Company Description (as filed with the SEC)

We are a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic® microbiome therapeutics. The human microbiome is an ecology of microorganisms, including bacteria, fungi and viruses, that, when unhealthy, or dysbiotic, can leave the body more susceptible to infections, metabolic disorders, allergies, autoimmune disease, inflammation and other serious conditions. Our drug candidates are designed to restore health by repairing the function of a dysbiotic microbiome. We are initially focused on implementing our microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome, one of the most diverse microbial ecologies in the human body. The human microbiome is one of the richest and most diverse ecosystems on earth, with a population of more than 40 trillion microorganisms that live in our intestines, mouth, skin and elsewhere in the body.  ... More ...  


Risk Grade

Where does MCRB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.19
Open Date:
Nov. 15, 2018
Close Price:
$ 8.21
Close Date:
Nov. 15, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x